Due to the ongoing search for effective drugs for the treatment of the novel coronavirus infection, specialists are paying close attention to antimicrobial agents that, in addition to their activity against various prokaryotes, exhibit antiviral activity. One such drug is the glycopeptide antibiotic teicoplanin (Ortocid).

For detailed information on the potential of teicoplanin as a therapeutic agent for COVID-19, please refer to the article "ORTOCID (Teicoplanin) as a Treatment for COVID-19."